US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist
  • 1.1700
  • +0.0300+2.63%
Close Mar 27 16:00 ET
3.82MMarket Cap-62P/E (TTM)

About Clearmind Medicine Company

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Company Profile

SymbolCMND
Company NameClearmind Medicine
Listing Date11/15/2022
Founded2017
CEODr. Adi Zuloff-Shani
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends10-31
Address1220 West 6th Avenue,Suite 101
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6H 1A5
Phone1-973-536-1016

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Adi Zuloff-Shani
  • Chief Executive Officer
  • --
  • Alan Rootenberg
  • Chief Financial Officer
  • --
  • Professor Mark Haden
  • Vice President, Business Development
  • --
  • Amitay Weiss
  • Chairman of the Board
  • --
  • Asaf Itzhaik
  • Director
  • --
  • Oz Adler
  • Independent Director
  • --
  • Yehonatan Shachar
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg